Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

24.88
+0.88003.67%
Post-market: 24.72-0.1600-0.64%19:30 EST
Volume:1.14M
Turnover:28.35M
Market Cap:2.75B
PE:-8.41
High:25.76
Open:24.61
Low:24.32
Close:24.00
52wk High:27.65
52wk Low:5.15
Shares:110.34M
Float Shares:93.80M
Volume Ratio:0.70
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9600
EPS(LYR):-4.9960
ROE:-93.04%
ROA:-46.48%
PB:10.40
PE(LYR):-4.98

Loading ...

BRIEF-Immunome Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Yesterday

Immunome Grants Stock Options to New Employee Under 2024 Inducement Plan

Reuters
·
Yesterday

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Yesterday

Immunome to Present at Guggenheim Emerging Outlook Biotech Summit

Reuters
·
Feb 04

Immunome (IMNM) Receives a Buy from Wedbush

TIPRANKS
·
Feb 04

Immunome Price Target Maintained With a $31.00/Share by Wedbush

Dow Jones
·
Jan 15

Wedbush Reaffirms Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Jan 15

Immunome Grants Stock Options to New Employees Under 2024 Inducement Plan

Reuters
·
Jan 09

Immunome Inc. CEO Clay B. Siegall Acquires Common Shares

Reuters
·
Dec 31, 2025

Immunome (IMNM): Assessing Valuation After Strong Phase 3 Varegacestat Data and $400 Million Equity Raise

Simply Wall St.
·
Dec 26, 2025

Immunome Inc. Director Isaac Barchas Reports Disposal of Common Shares

Reuters
·
Dec 24, 2025

Immunome CTO Philip Tsai Reports Acquisition of Common Shares

Reuters
·
Dec 22, 2025

Clay Siegall Bought 5.8% More Shares In Immunome

Simply Wall St.
·
Dec 20, 2025

Immunome CEO Clay B. Siegall Reports Acquisition of Common Shares

Reuters
·
Dec 19, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks

Reuters
·
Dec 17, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas Roadhouse

Reuters
·
Dec 17, 2025

BUZZ-Immunome slips after $400 mln stock sale

Reuters
·
Dec 17, 2025

Immunome Announces Pricing Of Public Offering Of 18,625,000 Shares At $21.50 Each

Reuters
·
Dec 17, 2025

Immunome Inc - Prices Public Offering of 18,625,000 Shares at $21.50 Each

THOMSON REUTERS
·
Dec 17, 2025

ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn

Reuters
·
Dec 17, 2025